Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Sets New Goal For Biosimilar, Drug Promotion Guidances

Jan 22 2016

• By Brenda Sandburg

Related Content

FDA’s Temple: Better Meta-Analyses Needed Ahead Of Agency Guidance

Nov 27 2013

FDA Will Allow ANDA Corrections … Until 10 Minor Deficiencies Found

Oct 01 2013

Social Media Marketing: FDA’s Old-Time Approach May Turn Industry Away

Jun 23 2014

FDA Promises More Off-label Guidances As Part Of First Amendment Harmonization

Jun 11 2014

FDA Guidance On Health Care Economic Data Is Coming In 2015

Jan 02 2015

Biosimilar Labeling Needs Greater Transparency, BIO And PhRMA Say

Jan 08 2016

FDA Wrangles With Generic Exclusivity, Looks To Courts For Direction

Oct 18 2010

Adaptive Trials Could Have A Steep Regulatory Learning Curve

Mar 08 2010

Related Companies

Amarin Corp plc

Pacira BioSciences, Inc.

AbbVie Inc.

Otsuka Holdings Co., Ltd.

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window